Literature DB >> 12496441

The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.

Bouchaib Lamkhioued1, Soussi Gounni Abdelilah, Qutayba Hamid, Nabil Mansour, Guy Delespesse, Paolo M Renzi.   

Abstract

The involvement of chemokines in eosinophil recruitment during inflammation and allergic reactions is well established. However, a functional role for chemokines in eosinophil differentiation has not been investigated. Using in situ RT-PCR, immunostaining, and flow cytometric analysis, we report that human CD34+ cord blood progenitor cells contain CCR3 mRNA and protein. Activation of CD34+ progenitor cells under conditions that promote Th2 type differentiation up-regulated surface expression of the CCR3. In contrast, activation with IL-12 and IFN-gamma resulted in a significant decrease in the expression of CCR3. Eotaxin induced Ca2+ mobilization in CD34+ progenitor cells, which could explain the in vitro and in vivo chemotactic responsiveness to eotaxin. We also found that eotaxin induced the differentiation of eosinophils from cord blood CD34+ progenitor cells. The largest number of mature eosinophils was found in cultures containing eotaxin and IL-5. The addition of neutralizing anti-IL-3, anti-IL-5, and anti-GM-CSF Abs to culture medium demonstrated that the differentiation of eosinophils in the presence of eotaxin was IL-3-, IL-5-, and GM-CSF-independent. These results could explain how CD34+ progenitor cells accumulate and persist in the airways and peripheral blood of patients with asthma and highlight an alternative mechanism by which blood and tissue eosinophilia might occur in the absence of IL-5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496441     DOI: 10.4049/jimmunol.170.1.537

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Local proliferation and mobilization of CCR3(+)  CD34(+) eosinophil-lineage-committed cells in the lung.

Authors:  Madeleine Rådinger; Apostolos Bossios; Margareta Sjöstrand; You Lu; Carina Malmhäll; Anna-Karin Dahlborn; James J Lee; Jan Lötvall
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

2.  Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses.

Authors:  Marcus Niemeyer; Alexandre Darmoise; Hans-Joachim Mollenkopf; Karin Hahnke; Robert Hurwitz; Gurdyal S Besra; Ulrich E Schaible; Stefan H E Kaufmann
Journal:  Immunology       Date:  2007-10-04       Impact factor: 7.397

3.  The human chorion contains definitive hematopoietic stem cells from the fifteenth week of gestation.

Authors:  Marcus O Muench; Mirhan Kapidzic; Matthew Gormley; Alan G Gutierrez; Kathryn L Ponder; Marina E Fomin; Ashley I Beyer; Haley Stolp; Zhongxia Qi; Susan J Fisher; Alicia Bárcena
Journal:  Development       Date:  2017-03-02       Impact factor: 6.868

4.  The early detection of asthma based on blood gene expression.

Authors:  Shao-Bin Wang; Tao Huang
Journal:  Mol Biol Rep       Date:  2018-11-12       Impact factor: 2.316

Review 5.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

6.  IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease.

Authors:  Charlotte Mitchell; Karin Provost; Naiqian Niu; Robert Homer; Lauren Cohn
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

Review 7.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

Review 8.  Immunomodulators in asthma therapy.

Authors:  Vesselin V Dimov; Jeffrey R Stokes; Thomas B Casale
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

9.  Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness.

Authors:  Milica Grozdanovic; Kimberly G Laffey; Hazem Abdelkarim; Ben Hitchinson; Anantha Harijith; Hyung-Geon Moon; Gye Young Park; Lee K Rousslang; Joanne C Masterson; Glenn T Furuta; Nadya I Tarasova; Vadim Gaponenko; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2018-05-17       Impact factor: 10.793

10.  Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation.

Authors:  Steven G Smith; Mike Hill; John-Paul Oliveria; Brittany M Watson; Adrian J Baatjes; Benny Dua; Karen Howie; Heather Campbell; Rick M Watson; Roma Sehmi; Gail M Gauvreau
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.